Clinical trial
To Study the Effect of Low Molecular Weight Heparin on the Adenomyosis Patients'Outcome of in Vitro Fertilization-embryo Transplantation
NCT04741295 is registered in ClinicalTrials.gov with Nanjing University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Study the Effect of Low Molecular Weight Heparin on the Adenomyosis Patients'Outcome of in Vitro Fertilization-embryo Transplantation
- Lead sponsor
- Nanjing University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 1, 2020
- Completion date
- January 31, 2022
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adenomyosis, assisted reproductive technology